Giuseppe Remuzzi
Remuzzi, Giuseppe.
Remuzzi, Giuseppe, 1949-
Remuzzi, Giuseppe, 1949-...., médecin
Remuzzi, G.
VIAF ID: 84867900 (Personal)
Permalink: http://viaf.org/viaf/84867900
Preferred Forms
- 100 0 _ ‡a Giuseppe Remuzzi
- 200 _ | ‡a Remuzzi ‡b Giuseppe
- 100 1 _ ‡a Remuzzi, G.
-
- 100 1 _ ‡a Remuzzi, Giuseppe
-
-
-
-
-
- 100 1 _ ‡a Remuzzi, Giuseppe ‡d 1949-
- 100 1 _ ‡a Remuzzi, Giuseppe ‡d 1949-
-
- 100 1 _ ‡a Remuzzi, Giuseppe, ‡d 1949-...., ‡c médecin
-
-
4xx's: Alternate Name Forms (14)
5xx's: Related Names (5)
- 551 _ _ ‡a Bergamo ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 551 _ _ ‡a Bergamo ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 551 _ _ ‡a Mailand ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Università degli studi di Milano ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Università degli studi di Pavia ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney | |
Blocking cell microtubule assembly inhibits the alloimmune response in vitro and prolongs renal allograft survival by inhibition of Th1 and sparing of Th2 cell function in vivo | |
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial | |
Blunted excretory response to atrial natriuretic peptide in experimental nephrosis | |
Bone Marrow Mesenchymal Stem Cells in Organ Repair and Strategies to Optimize their Efficacy | |
Building a network of ADPKD reference centres across Europe: the EuroCYST initiative | |
Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs | |
C3 glomerulopathy - understanding a rare complement-driven renal disease | |
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial | |
Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium. | |
Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction. | |
Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion | |
Can We Really Lessen Kidney Damage to the Point that the Loss of Renal Function of Progressive Nephropathy May Revert? | |
Candesartan and renal protection: more than blocking angiotensin type 1 receptor? | |
Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings | |
Catecholamine receptor binding in rat kidney: Effect of aging | |
Cavour's death and the political difficulties of Italian medicine – Author's reply | |
CD133+ renal stem cells always co-express CD24 in adult human kidney tissue. | |
Cells for treating organ damage: how long will we need them? | |
Cellular basis of long-term organ transplant acceptance: pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance | |
Cellular responses to protein overload: key event in renal disease progression | |
Challenges in Understanding Acute Postinfectious Glomerulonephritis: Are Anti-Factor B Autoantibodies the Answer? | |
Challenges to achieving clinical transplantation tolerance | |
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial | |
Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement | |
Characterization of mutations in complement factor I | |
Child and Adolescent Health From 1990 to 2015: Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study | |
Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism | |
Chronic kidney disease: a research and public health priority | |
Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. | |
Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model | |
Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury | |
Chronic renal diseases as a public health problem: epidemiology, social, and economic implications | |
Ci curano o ci curiamo? : il malato tra crisi economica e responsabilità individuale | |
Cigarette smoking and renal function impairment | |
Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy | |
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study | |
Clinical perspectives in the prevention and treatment of chronic nephropathy, including an overview of the DEMAND Study | |
Clinical practice. Nephropathy in patients with type 2 diabetes | |
Clinical problem solving. The girl with the curl | |
Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology. | |
Clinical trials: ISN-ACCTS: global initiatives to improve clinical research. | |
Clinical update: immunosuppression minimisation | |
Clinical use of computational modeling for surgical planning of arteriovenous fistula for hemodialysis | |
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN. | |
Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure | |
Coagulation defects in uremia | |
Colchicine allows prolonged survival of highly reactive renal allograft in the rat | |
Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation | |
Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart? | |
Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft. | |
Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals | |
Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis | |
Comment on: Robertson (2010) Islet Transplantation a Decade Later and Strategies for Filling a Half-Full Glass. Diabetes;59:1285-1291 | |
Commenti alla delibera | |
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. | |
Current and future immunosuppressive therapies following transplantation | |
Drugs and kidney, c1986: | |
Gene Therapy for Renal Diseases and Transplantation | |
Haemostasis and the kidney | |
Hemolytic uremic syndrome | |
Hemostasis, prostaglandins, and renal disease | |
Ho sognato un mondo senza cancro | |
Humoral Immunity in Kidney Transplantation What Clinicians Need to Know | |
Le impronte del signor Neanderthal : come la scienza ricostruisce il passato e disegna il futuro | |
Kidney transplantation, bioengineering, and regeneration : kidney transplantation in the regenerative medicine era | |
Kidney transplantation : strategies to prevent organ rejection | |
A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity | |
Le monetine di Roosevelt : una storia dell'umanità attraverso i vaccini | |
Need for chronic kidney disease prevention programs in disadvantaged populations | |
Nephrology and Public Health Worldwide | |
New strategies to prevent cardiovascular risk in chronic Kidney disease. | |
Oxford textbook of clinical nephrology. | |
A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis | |
Rare kidney diseases | |
Renal protective effect of ACE inhibition and angiotensin II blockade | |
Renal transplant tolerance molecular mechanisms of T-cell regulation ; special symposium issue ; 5 tables | |
La salute (non) è in vendita | |
La scelta | |
Thrombotic microangiopathy in renal transplantation |